View More Recent Stories

Apr 6, 2022 07:00AM PolyPid Secures $15 Million Non-Dilutive Secured Term Loan Facility
Mar 8, 2022 07:00AM PolyPid to Deliver Poster Presentation at SAGES 2022
Mar 2, 2022 07:00AM PolyPid Announces 750th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ in Abdominal Surgery
Mar 1, 2022 07:00AM PolyPid to Present at the Barclays Global Healthcare Conference
Feb 9, 2022 07:00AM PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
Jan 26, 2022 07:30AM PolyPid to Report Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights on February 9, 2022
Jan 4, 2022 07:30AM PolyPid Appoints UCSF Brain Tumor Center Director Mitchel S. Berger, M.D., to Oncology Advisory Board
Jan 3, 2022 07:30AM PolyPid Ltd. (PYPD) Announces Upcoming CEO Transition
Jan 3, 2022 07:30AM PolyPid Announces Planned CEO Transition
Nov 18, 2021 07:00AM PolyPid Announces 500th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ in Abdominal Surgery
Nov 16, 2021 07:00AM PolyPid Appoints New Oncology Advisory Board Member
Nov 10, 2021 07:00AM PolyPid Ltd. Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Nov 1, 2021 07:00AM PolyPid to Report Third Quarter 2021 Financial Results and Operational Highlights on November 10, 2021
Sep 20, 2021 07:00AM PolyPid to Present at Upcoming Cantor Fitzgerald Global Healthcare Conference
Sep 13, 2021 07:33AM PolyPid (PYPD) Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cancer
Sep 13, 2021 07:30AM PolyPid Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cancer
Aug 17, 2021 08:00AM PolyPid to Present at First World Association Against Infection in Orthopaedics and Trauma Congress
Aug 11, 2021 07:00AM PolyPid Ltd. Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Aug 9, 2021 08:00AM PolyPid to Present at the Investor Summit Virtual Conference on August 18, 2021
Jul 28, 2021 07:00AM PolyPid to Report Second Quarter 2021 Financial Results and Operational Highlights on August 11, 2021
Jul 12, 2021 08:00AM PolyPid Strengthens Executive Team, Appointing Dr. Anthony Senagore as Senior Medical Director
Jun 23, 2021 06:30AM PolyPid Presents today at The Raymond James Human Health Innovation Conference
Jun 2, 2021 09:10AM PolyPid to Present at Upcoming Healthcare Investor Conferences
May 19, 2021 08:02AM PolyPid Ltd. (PYPD) Announces Positive FDA Type B Meeting Feedback for D-PLEX₁₀₀ Development Program
May 19, 2021 08:00AM PolyPid Announces Positive FDA Type B Meeting Feedback for D-PLEX₁₀₀ Development Program
May 12, 2021 07:00AM PolyPid Ltd. Reports First Quarter 2021 Financial Results and Provides Corporate Update
Apr 29, 2021 07:00AM PolyPid to Report First Quarter 2021 Financial Results and Operational Highlights on May 12, 2021
Feb 23, 2021 07:30AM PolyPid to Participate in Upcoming Investor Conferences
Feb 16, 2021 07:30AM PolyPid Announces 100th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional Infections
Feb 10, 2021 07:00AM PolyPid Ltd. Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
Jan 27, 2021 07:30AM PolyPid to Report Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights on February 10, 2021
View More Recent Stories